Stem Cell-Derived Blood Products for Therapeutic Use (R01)
Funding Opportunity Number: RFA-HL-15-022 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.839Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the I...
Source: Grants.gov - November 8, 2014 Category: Research Tags: Health Source Type: funding
Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)
Funding Opportunity Number: RFA-HL-15-030 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.839Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Feb 20, 2017Award Ceiling: Expected Number of Awards: Creation Date: Nov 07, 2014Funding Opportunity Description: The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platelets in a mo...
Source: Grants.gov - November 8, 2014 Category: Research Tags: Health Source Type: funding
Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R41)
Funding Opportunity Number: RFA-HL-15-029 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.839Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Feb 20, 2015Award Ceiling: $225,000Expected Number of Awards: 3Creation Date: Nov 07, 2014Funding Opportunity Description: The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platele...
Source: Grants.gov - November 8, 2014 Category: Research Tags: Health Source Type: funding
Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)
Funding Opportunity RFA-HL-15-030 from the NIH Guide for Grants and Contracts. The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platelets in a more efficient and cost-effective manner. The research supported will develop and enhance technologies that enable the production of functional stem cell-based therapies with potential commercial and clinical viability. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2014 Category: Research Source Type: funding
Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R41)
Funding Opportunity RFA-HL-15-029 from the NIH Guide for Grants and Contracts. The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platelets in a more efficient and cost-effective manner. The research supported will develop and enhance technologies that enable the production of functional stem cell-based therapies with potential commercial and clinical viability. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2014 Category: Research Source Type: funding
Stem Cell-Derived Blood Products for Therapeutic Use (R01)
Funding Opportunity RFA-HL-15-022 from the NIH Guide for Grants and Contracts. Stem cell technology holds the promise of providing a nearly limitless source of safe, immune-matched cells for clinical use. One of the first areas where this promise can be realized is through cell products that lack a nucleus and thus face fewer regulatory hurdles, such as red blood cells and platelets. Considerable progress has been made but scientific questions remain and improved tools to enhance the production are required if translation to clinical use is to be achieved. To this end, this FOA will support research addressing rema...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2014 Category: Research Source Type: funding
Glenn/American Federation for Aging Research Scholarships for Research in the Biology of Aging
The deadline for applications for the 2015 awards is January 15, 2015. It is a well-known fact that America’s population is aging dramatically – it is estimated that 20% of the population will be 65 years of age and older by 2030. This aging population poses unique scientific and medical challenges that must be met if people are to live long, healthy, and productive lives. Significant research findings in the biology of aging can lead to advances that help people live longer and healthier lives. In order to continue to attract new generations of talented investigators, the Glenn/AFAR Sc...
Source: ScanGrants feed - October 28, 2014 Category: Research Authors: Glenn Foundation for Medical Research/American Federation for Aging Research Source Type: funding
American Federation for Aging Research Research Grants for Junior Faculty
Deadline: December 15, 2014 AFAR provides up to $100,000 for a one- to two-year award to junior faculty (M.D.s and Ph.D.s) to conduct research that will serve as the basis for longer term research efforts. AFAR-supported investigators study a broad range of biomedical and clinical topics including the causes of cellular senescence, the role of estrogen in the development of osteoporosis, the genetic factors associated with Alzheimer's disease, the effects of nutrition and exercise on the aging process, and much more. Since 1981, over 690 AFAR Research Grants have been awarded. The Program The major goa...
Source: ScanGrants feed - October 28, 2014 Category: Research Authors: American Federation for Aging Research Source Type: funding
2014-2015 Cure HHT Young Research Scholar Awards
Cure HHT, formerly known as HHT Foundation International, Inc., is providing awards to attract new researchers in the field of HHT. Applications are encouraged in the following areas: Basic mechanism of AVM formation Signaling downstream of Alk1 and Endoglin Cellular crosstalk in HHT Stem cells in HHT Modifier genes In vitro and in vivo HHT models Funding Period and Amount of Award: One year up to $30,000. No overhead or indirect costs will be provided. Eligibility: Applicants must hold a Ph.D. and be no more than 5 years beyond completion of their post doctoral training...
Source: ScanGrants feed - October 28, 2014 Category: Research Authors: Cure HHT Source Type: funding
Notice to Inform Potential Applicants to RFA-NS-14-006 "High Impact Neuroscience Research Resource Grants (R24)" of NINDS Policies on Induced Pluripotent Stem Cell Development and Resource Sharing
Notice NOT-NS-14-044 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2014 Category: Research Source Type: funding
Request for Applications: Postdoctoral Fellowship for Research Related to Niemann Pick Type C
The CODRT Postdoctoral Fellowship provides a one-year grant of $35,000 to support the salary of a Fellow while working on a mentored project related to a CODRT-funded disease. Eligibility At the time of application, the applicant must possess a Ph.D., M.D., or V.M.D. and should not have completed more than 5 years of postdoctoral research. At the time of award, the applicant must not be simultaneously serving an internship or residency. Applicants must work for a non-profit institution or foundation, and may not have a faculty appointment. There are no citizenship requirements for this program. Research Fo...
Source: ScanGrants feed - September 3, 2014 Category: Research Authors: Center for Orphan Disease Research and Therapy University of Pennsylvania Source Type: funding
Request for Applications: Pilot Grant for Research on Niemann Pick Type C
Eligibility All individuals holding a faculty-level appointment at an academic institution or a senior scientific position at a non-profit institution or foundation are eligible to respond to this RFA. Research Focus: The following areas of investigation will be considered in the context of a $50,000 pilot grant for Niemann Pick Type C. 1. EVALUATING INVOLVEMENT OF HEAT SHOCK PROTEINS IN THERAPY (but not by groups presently publishing on potential therapies already ex: HSP70) 2. Studies on methods and drugs to increase NPC1 protein expression to delay onset. 3. Studies intended to SPECIFICALLY ...
Source: ScanGrants feed - September 3, 2014 Category: Research Authors: Center for Orphan Disease Research and Therapy University of Pennsylvania Source Type: funding
Request for Applications: Postdoctoral Fellowship for Research Related to Tay-Sachs & Allied Diseases
Request for Applications: Postdoctoral Fellowship for Research Related to Tay-Sachs & Allied Diseases The CODRT Postdoctoral Fellowship provides a one-year grant of $35,000 to support the salary of a Fellow while working on a mentored project related to a CODRT-funded disease. Eligibility At the time of application, the applicant must possess a Ph.D., M.D., or V.M.D. and should not have completed more than 5 years of postdoctoral research. At the time of award, the applicant must not be simultaneously serving an internship or residency. Applicants must work for a non-profit institution or foundation, and ma...
Source: ScanGrants feed - September 3, 2014 Category: Research Authors: Center for Orphan Disease Research and Therapy University of Pennsylvania Source Type: funding
National Blood Foundation Scientific Research Grants Program
Submit the application by 11:59pm ET December 31, 2014. Application fee of $150 must accompany the application unless the primary investigator is an AABB individual member. The National Blood Foundation annually awards grants for one or two-year research projects, with a maximum award per grant of $75,000. NBF is pleased to announce the availability of funding in 2015 for scientific research projects related to transfusion medicine and cellular therapies. NBF will award grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient ...
Source: ScanGrants feed - August 25, 2014 Category: Research Authors: National Blood Foundation Source Type: funding
Musculoskeletal Transplant Foundation Research Grant
Deadline: Sept. 16, 2014 $98,000 grant ($49,000 per year) (Directed program) • The Orthopaedic Research and Education Foundation in partnership with the Musculoskeletal Transplant Foundation (MTF) offers seed money for new investigators conducting research on biologic skeletal reconstruction, including implants and stem cells. • Research may be basic or clinical. • Clinical relevance must be clearly noted in the abstract and specific aims and be obvious from the title and study design. • PI or Co-PI must be an orthopaedic surgeon. • PhDs and DVMs are eligible if affilia...
Source: ScanGrants feed - June 11, 2014 Category: Research Authors: Musculoskeletal Transplant Foundation/Orthopaedic Research and Education Foundation Source Type: funding
